Get Premium to unlock powerful stock data
NYSE:RMD (USA)  
ResMed Inc logo

ResMed Inc

$ 216.43 +0.71 (+0.33%) 10:08 PM EST
P/E:
40.76
P/B:
9.65
Market Cap:
$ 31.66B
Enterprise V:
$ 32.29B
Volume:
504.59K
Avg Vol (2M):
620.32K
Also Trade In:
Volume:
504.59K
Market Cap $:
31.66B
PE Ratio:
40.76
Avg Vol (2-Month):
620.32K
Enterprise Value $:
32.29B
PB Ratio:
9.65
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Description
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Financials (Next Earnings Date:2022-08-05 Est.)

RMD's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NYSE:RMD

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 3,539.492
EPS (TTM) ($) 5.31
Beta 0.52
Volatility % 29.23
14-Day RSI 60.24
14-Day ATR ($) 5.731631
20-Day SMA ($) 207.9135
12-1 Month Momentum % -16.85
52-Week Range ($) 189.4 - 301.34
Shares Outstanding (Mil) 146.28

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ResMed Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More